share_log

EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit

EDETEK to Present Keynote Presentation at 15th Clinical Trials Strategic Summit

EDETEK將在第十五屆臨床試驗戰略峯會上發表主題演講
PR Newswire ·  05/01 02:38

Presentation will Address Solutions to Real-Time Management of Complex Clinical Data

演講將討論複雜臨床數據實時管理的解決方案

PRINCETON, N.J., April 30, 2024 /PRNewswire/ -- EDETEK Inc., a leading global provider of comprehensive, fully integrated platforms and services for clinical development across the biopharma, medical devices, and diagnostics industries, announced today that it will be a platinum sponsor and present 15th Clinical Trials Strategic Summit (CTSS), May 1-2, 2024, Boston, MA. Munther Baara, VP, Product Strategy & Innovation, EDETEK, Inc. will deliver a keynote presentation entitled, "Unlock Clinical Data to Guide Agile Decision Making." This presentation takes place on Wednesday, May 1 at 1:30pm ET.

新澤西州普林斯頓,2024年4月30日 /PRNewswire/ — 爲生物製藥、醫療器械和診斷行業臨床開發提供全面、完全集成的全球領先平台和服務的全球領先提供商EDETEK Inc. 今天宣佈,它將成爲白金贊助商,並將於2024年5月1日至2日在馬薩諸塞州波士頓出席第15屆臨床試驗戰略峯會(CTSS)。EDETEK, Inc.產品戰略與創新副總裁Munther Baara將發表題爲 “解鎖臨床數據以指導敏捷決策” 的主題演講。本次演講將於美國東部時間5月1日星期三下午 1:30 舉行。

"In the fast-paced world of clinical trials, the ability to swiftly unlock and interpret complex data sets is crucial for agile decision-making," said Mr. Baara. "Innovative solutions from EDETEK not only streamline data processes but also harness the power of advanced analytics to deliver actionable insights, ensuring higher quality outcomes and accelerating clinical trial lifecycles."

巴拉說:“在快節奏的臨床試驗世界中,快速解鎖和解釋複雜數據集的能力對於敏捷決策至關重要。”“EDETEK的創新解決方案不僅可以簡化數據流程,還可以利用高級分析的力量來提供切實可行的見解,確保更高質量的結果並加快臨床試驗生命週期。”

This presentation explores EDETEK's innovative solutions that empower sponsors to seamlessly access, analyze, and act upon clinical data. Mr. Baara's presentation will highlight the role of the CONFORM informatics platform and how this innovative software tool delivers foundational and fundamental solutions in an ever-changing clinical informatics ecosystem.

本演示探討了EDETEK的創新解決方案,這些解決方案使申辦方能夠無縫訪問、分析臨床數據並據此採取行動。Baara先生的演講將重點介紹CONFORM信息學平台的作用,以及這種創新的軟件工具如何在不斷變化的臨床信息學生態系統中提供基礎和基礎解決方案。

CONFORM is a powerful, purpose-built software platform that positively impacts the speed and quality of clinical trial execution by providing the ability to connect, collect, conform, and consume clinical trial data while conforming to state-of-the industry standards and regulations all in one, seamless, integrated solution.

CONFORM 是一款功能強大、專門構建的軟件平台,通過提供連接、收集、整合和使用臨床試驗數據的能力,同時符合行業最新標準和法規,集於一個無縫的集成解決方案中,從而對臨床試驗執行的速度和質量產生積極影響。

"EDETEK provides comprehensive metadata driven solutions to fulfill an enterprise's data engineering and business analytics needs, through excellence in technology and its applications, plus deep and broad IT industry knowledge," says Jian Chen, CEO, EDETEK, Inc. "It is a privilege to participate in the 2024 CTSS conference. We are excited to discuss how our precisely targeted solutions can exceed critical data management and analysis objectives thereby helping assure quality, speed, and cost efficiencies."
Please visit us at our booth number #9.

EDETEK, Inc.首席執行官陳健說:“EDETEK通過卓越的技術及其應用,以及深入而廣泛的IT行業知識,提供全面的元數據驅動解決方案,以滿足企業的數據工程和業務分析需求。” 能夠參加2024年CTSS會議是一種榮幸。我們很高興地討論我們的精確目標解決方案如何超越關鍵數據管理和分析目標,從而幫助確保質量、速度和成本效益。”
請訪問我們的展位號 #9。

About EDETEK
Founded in 2009, EDETEK is an innovative clinical solutions company that provides high-quality technology platforms and related clinical services to pharmaceutical, biotechnology, and medical device companies. With over 450 employees on 4 continents, EDETEK's commitment to excellence remains unwavering as it collaborates with over 100 biopharmaceutical companies.

關於 EDETEK
EDETEK成立於2009年,是一家創新的臨床解決方案公司,爲製藥、生物技術和醫療器械公司提供高質量的技術平台和相關的臨床服務。EDETEK在四大洲擁有450多名員工,與100多家生物製藥公司合作,對卓越的承諾堅定不移。

Learn more at or reach out to [email protected].

要了解更多信息,請訪問或聯繫 [email protected]。

Media Contact:
John F. Kouten
JFK Communications, Inc.
908-227-4714
[email protected]

媒體聯繫人:
約翰·F·庫滕
肯尼迪通訊公司
908-227-4714
[電子郵件保護]

SOURCE EDETEK, Inc.

來源 EDETEK, Inc.

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論